Hungtington’s Orphan Drug Xenazine Clears FDA With REMS
This article was originally published in The Pink Sheet Daily
Executive Summary
The first drug approved in the U.S. for any symptom of Huntington’s, Prestwick’s tetrabenazine will launch by year end.